Musculoskeletal manifestations of lysosomal storage disorders
- PMID: 19822711
- DOI: 10.1136/ard.2008.095315
Musculoskeletal manifestations of lysosomal storage disorders
Abstract
Lysosomal storage disorders (LSDs), a heterogeneous group of inborn metabolic disorders, are far more common than most doctors presume. Although patients with a severe LSD subtype are often readily diagnosed, the more attenuated subtypes are frequently missed or diagnosis is significantly delayed. The presenting manifestations often involve the bones and/or joints and therefore these patients are frequently under specialist care by (paediatric) rheumatologists, receiving inadequate treatment. Since effective disease-specific treatments, including enzyme replacement therapy and stem cell transplantation, have become available for certain LSDs and timely initiation of these treatments is necessary to prevent the development of severe, disabling and irreversible manifestations, early diagnosis has become essential. The challenge is to raise awareness for better recognition of the presenting signs and symptoms of LSDs by all doctors who may encounter these patients, including rheumatologists.
Similar articles
-
[Lysosomal storage diseases].Z Rheumatol. 2010 Aug;69(6):527-38. doi: 10.1007/s00393-010-0627-z. Z Rheumatol. 2010. PMID: 20532791 Review. German.
-
[Lysosomal disorders].Ryoikibetsu Shokogun Shirizu. 2002;(37 Pt 6):173-80. Ryoikibetsu Shokogun Shirizu. 2002. PMID: 12483855 Review. Japanese. No abstract available.
-
Musculoskeletal manifestations of mucopolysaccharidoses.Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v19-25. doi: 10.1093/rheumatology/ker397. Rheumatology (Oxford). 2011. PMID: 22210666 Review.
-
[Musculoskeletal manifestations in lysosomal storage diseases].Reumatizam. 2011;58(2):182-4. Reumatizam. 2011. PMID: 22232961 Review. Croatian.
-
Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.Clin Respir J. 2020 May;14(5):422-429. doi: 10.1111/crj.13150. Epub 2020 Jan 22. Clin Respir J. 2020. PMID: 31912638 Review.
Cited by
-
Therapies for the bone in mucopolysaccharidoses.Mol Genet Metab. 2015 Feb;114(2):94-109. doi: 10.1016/j.ymgme.2014.12.001. Epub 2014 Dec 9. Mol Genet Metab. 2015. PMID: 25537451 Free PMC article. Review.
-
Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.Orphanet J Rare Dis. 2016 Jul 8;11(1):93. doi: 10.1186/s13023-016-0470-7. Orphanet J Rare Dis. 2016. PMID: 27392569 Free PMC article.
-
Diagnosing mucopolysaccharidosis IVA.J Inherit Metab Dis. 2013 Mar;36(2):293-307. doi: 10.1007/s10545-013-9587-1. Epub 2013 Feb 1. J Inherit Metab Dis. 2013. PMID: 23371450 Free PMC article.
-
Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments.Int J Mol Sci. 2018 Oct 8;19(10):3063. doi: 10.3390/ijms19103063. Int J Mol Sci. 2018. PMID: 30297617 Free PMC article. Review.
-
Genetic Screening of Mutations Associated with Fabry Disease in a Nationwide Cohort of Juvenile Idiopathic Arthritis Patients.Front Med (Lausanne). 2017 Mar 1;4:12. doi: 10.3389/fmed.2017.00012. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28299312 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources